Hjem › Metaboliske lidelser › Illinois
Metaboliske lidelser kliniske forsøg i Illinois
6 studier for Metaboliske lidelser søger deltagere på steder i Illinois.
Byer i Illinois
Officiel studietekst (engelsk)
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
- Endeavor Health - Family Medicine Administration, Evanston
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07595549A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chicago
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Chicago
- 89bio Clinical Study Site, Glenview
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 3. sep. 2026 · NCT06419374A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
- University of Illinois Hospital & Health Sciences System, Chicago
RekruttererFase 1/2
Alder 35 til 70 · Alle køn · Opdateret 21. aug. 2026 · NCT06575426Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago
RekruttererFase 1/2
Alle aldre · Alle køn · Opdateret 22. jan. 2026 · NCT04159103Rare and Atypical Diabetes Network
- University of Chicago, Chicago
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 14. aug. 2025 · NCT05544266Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.